Study Title and Description
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.
Key Questions Addressed
|7||Key Question 7. What is the effectiveness of currently recommended antiviral treatments in achieving a SVR in patients with HCV infection?|
|8||Key Question 8. What are the harms of currently recommended antiviral treatments?|
Primary Publication Information
|Title||Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.|
|Author||Lalezari J., Sullivan JG., Varunok P., Galen E., Kowdley KV., Rustgi V., Aguilar H., Felizarta F., McGovern B., King M., Polepally AR., Cohen DE.|
|Country||Quest Clinical Research, San Francisco, CA, United States. Electronic address: firstname.lastname@example.org.|
Pubmed ID: 25839406
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Key Questions 1-9
Results & Comparisons
No Results found.